Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Comprehensive protection of a patient with atrial fibrillation (AF) should not only reduce the risk of stroke and systemic embolism, but also reduce the risk coronary events and ensure high adherence to treatment. In accordance with consensus document issued by the European Heart Rhythm Association,...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Online Access: | https://www.rpcardio.online/jour/article/view/2546 |